Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial

Background The efficacy of low‐voltage‐area (LVA) ablation has not been well determined. This study aimed to investigate the efficacy of LVA ablation in addition to pulmonary vein isolation on rhythm outcomes in patients with paroxysmal atrial fibrillation (AF). Methods and Results VOLCANO (Catheter...

Full description

Bibliographic Details
Main Authors: Masaharu Masuda, Mitsutoshi Asai, Osamu Iida, Shin Okamoto, Takayuki Ishihara, Kiyonori Nanto, Takashi Kanda, Takuya Tsujimura, Yasuhiro Matsuda, Shota Okuno, Yosuke Hata, Toshiaki Mano
Format: Article
Language:English
Published: Wiley 2020-07-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.120.015927
_version_ 1818314839157637120
author Masaharu Masuda
Mitsutoshi Asai
Osamu Iida
Shin Okamoto
Takayuki Ishihara
Kiyonori Nanto
Takashi Kanda
Takuya Tsujimura
Yasuhiro Matsuda
Shota Okuno
Yosuke Hata
Toshiaki Mano
author_facet Masaharu Masuda
Mitsutoshi Asai
Osamu Iida
Shin Okamoto
Takayuki Ishihara
Kiyonori Nanto
Takashi Kanda
Takuya Tsujimura
Yasuhiro Matsuda
Shota Okuno
Yosuke Hata
Toshiaki Mano
author_sort Masaharu Masuda
collection DOAJ
description Background The efficacy of low‐voltage‐area (LVA) ablation has not been well determined. This study aimed to investigate the efficacy of LVA ablation in addition to pulmonary vein isolation on rhythm outcomes in patients with paroxysmal atrial fibrillation (AF). Methods and Results VOLCANO (Catheter Ablation Targeting Low‐Voltage Areas After Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation Patients) trial included paroxysmal AF patients undergoing initial AF ablation. Of 398 patients in whom a left atrial voltage map was obtained after pulmonary vein isolation, 336 (85%) had no LVA (group A). The remaining 62 (15%) patients with LVAs were randomly allocated to undergo LVA ablation (group B, n=30) or not (group C, n=32) in a 1:1 fashion. Primary end point was 1‐year AF‐recurrence‐free survival rate. No adverse events related to LVA ablation occurred. Procedural (124±40 versus 95±33 minutes, P=0.003) and fluoroscopic times (29±11 versus 24±8 minutes, P=0.034) were longer in group B than group C. Patients with LVAs demonstrated lower AF‐recurrence‐free survival rates (88%) than those without LVA (B, 57%, P<0.0001; C, 53%, P<0.0001). However, LVA ablation in addition to pulmonary vein isolation did not impact AF‐recurrence‐free survival rate (group B versus C, P=0.67). Conclusions The presence of LVA was a strong predictor of AF recurrence after pulmonary vein isolation in patients with paroxysmal AF. However, LVA ablation had no beneficial impact on 1‐year rhythm outcomes. Registration URL: https://www.umin.ac.jp/ctr; Unique identifier: UMIN000023403.
first_indexed 2024-12-13T08:56:01Z
format Article
id doaj.art-2ffbf190519b4656a9d1fe84714a0920
institution Directory Open Access Journal
issn 2047-9980
language English
last_indexed 2024-12-13T08:56:01Z
publishDate 2020-07-01
publisher Wiley
record_format Article
series Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
spelling doaj.art-2ffbf190519b4656a9d1fe84714a09202022-12-21T23:53:16ZengWileyJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease2047-99802020-07-0191310.1161/JAHA.120.015927Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO TrialMasaharu Masuda0Mitsutoshi Asai1Osamu Iida2Shin Okamoto3Takayuki Ishihara4Kiyonori Nanto5Takashi Kanda6Takuya Tsujimura7Yasuhiro Matsuda8Shota Okuno9Yosuke Hata10Toshiaki Mano11Kansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanKansai Rosai Hospital Cardiovascular Center Hyogo JapanBackground The efficacy of low‐voltage‐area (LVA) ablation has not been well determined. This study aimed to investigate the efficacy of LVA ablation in addition to pulmonary vein isolation on rhythm outcomes in patients with paroxysmal atrial fibrillation (AF). Methods and Results VOLCANO (Catheter Ablation Targeting Low‐Voltage Areas After Pulmonary Vein Isolation in Paroxysmal Atrial Fibrillation Patients) trial included paroxysmal AF patients undergoing initial AF ablation. Of 398 patients in whom a left atrial voltage map was obtained after pulmonary vein isolation, 336 (85%) had no LVA (group A). The remaining 62 (15%) patients with LVAs were randomly allocated to undergo LVA ablation (group B, n=30) or not (group C, n=32) in a 1:1 fashion. Primary end point was 1‐year AF‐recurrence‐free survival rate. No adverse events related to LVA ablation occurred. Procedural (124±40 versus 95±33 minutes, P=0.003) and fluoroscopic times (29±11 versus 24±8 minutes, P=0.034) were longer in group B than group C. Patients with LVAs demonstrated lower AF‐recurrence‐free survival rates (88%) than those without LVA (B, 57%, P<0.0001; C, 53%, P<0.0001). However, LVA ablation in addition to pulmonary vein isolation did not impact AF‐recurrence‐free survival rate (group B versus C, P=0.67). Conclusions The presence of LVA was a strong predictor of AF recurrence after pulmonary vein isolation in patients with paroxysmal AF. However, LVA ablation had no beneficial impact on 1‐year rhythm outcomes. Registration URL: https://www.umin.ac.jp/ctr; Unique identifier: UMIN000023403.https://www.ahajournals.org/doi/10.1161/JAHA.120.015927ablationatrial fibrillationlow‐voltage areaparoxysmalrecurrence
spellingShingle Masaharu Masuda
Mitsutoshi Asai
Osamu Iida
Shin Okamoto
Takayuki Ishihara
Kiyonori Nanto
Takashi Kanda
Takuya Tsujimura
Yasuhiro Matsuda
Shota Okuno
Yosuke Hata
Toshiaki Mano
Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
ablation
atrial fibrillation
low‐voltage area
paroxysmal
recurrence
title Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial
title_full Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial
title_fullStr Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial
title_full_unstemmed Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial
title_short Additional Low‐Voltage‐Area Ablation in Patients With Paroxysmal Atrial Fibrillation: Results of the Randomized Controlled VOLCANO Trial
title_sort additional low voltage area ablation in patients with paroxysmal atrial fibrillation results of the randomized controlled volcano trial
topic ablation
atrial fibrillation
low‐voltage area
paroxysmal
recurrence
url https://www.ahajournals.org/doi/10.1161/JAHA.120.015927
work_keys_str_mv AT masaharumasuda additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT mitsutoshiasai additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT osamuiida additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT shinokamoto additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT takayukiishihara additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT kiyonorinanto additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT takashikanda additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT takuyatsujimura additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT yasuhiromatsuda additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT shotaokuno additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT yosukehata additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial
AT toshiakimano additionallowvoltageareaablationinpatientswithparoxysmalatrialfibrillationresultsoftherandomizedcontrolledvolcanotrial